Achieving the composite endpoint of glycated haemoglobin <7.0%, no weight gain and no hypoglycaemia in the once‐weekly dulaglutide AWARD programme

AIM: To compare the effectiveness of dulaglutide 1.5 and 0.75 mg with active comparators and placebo with regard to a composite endpoint of glycated haemoglobin (HbA1c), weight and hypoglycaemia, using post hoc analyses. METHODS: A logistic regression analysis was performed on the intention‐to‐treat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Diabetes Obes Metab
Autori principali: Dungan, K. M., Raz, I., Skrivanek, Z., Sealls, W., Fahrbach, J. L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Blackwell Publishing Ltd 2016
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5061097/
https://ncbi.nlm.nih.gov/pubmed/26362460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12575
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi